3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
18
Phase 2
13
Phase 1/2
4
Phase 4
2
Phase 1
2
Phase NA
1
Phase 2/3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Urinary Bladder Neoplasms
2
Recurrence
1
Non-Muscle Invasive Bladder Neoplasms
1
Head and Neck Neoplasms
1
Conjunctival Intraepithelial Neoplasia
1
Interventions
Rocuronium
2
Ofloxacin
2
Mitomycin
2
5-aminolevulinic acid hexyl ester
2
remimazolam
1
penpulimab
1
pembrolizumab
1
mebeverine
1
lornoxicam
1
enfortumab vedotin
1
disitamab vedotin
1
Ultrasonography
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Tobacco Use Cessation Devices
1
Tamsulosin
1
Sugammadex
1
Specimen Handling
1
Psychiatric Rehabilitation
1
Propofol
1
Polymerase Chain Reaction
1
Nitrofurantoin
1
Neuromuscular Blockade
1
Neuroleptanalgesia
1
Nephroureterectomy
1
Neostigmine
1
Midazolam
1
Metformin
1
Mepivacaine
1
Magnetic Resonance Spectroscopy
1
Levofloxacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Urinary Bladder Neoplasms
×
Mitomycin
×
Clear all
NCT03348969
2026-03-03
NICSA
Aarhus University Hospital
Phase 4
Completed
120 enrolled
NCT03790384
2018-12-31
MITOBCG
Azienda Ospedaliera "Sant'Andrea"
Phase 4
Unknown
140 enrolled